Â¥
13.34
Jan 15
New Key Statistics Module, Z-Score and F-Score
SZSE:002275 Key Ratios
Market Cap ¥ M | 7,914.61 |
Enterprise Value ¥ M | 7,006.41 |
P/E(ttm) | 19.33 |
PE Ratio without NRI | 19.28 |
Forward PE Ratio | -- |
Price/Book | 2.58 |
Price/Sales | 3.72 |
Price/Free Cash Flow | 16.16 |
Price/Owner Earnings | 26.37 |
Payout Ratio % | 0.87 |
Revenue (TTM) ¥ M | 2,114.00 |
EPS (TTM) ¥ | 0.69 |
Beneish M-Score | -2.63 |
10-y EBITDA Growth Rate % | 0.80 |
5-y EBITDA Growth Rate % | 2.80 |
y-y EBITDA Growth Rate % | -11.50 |
EV-to-EBIT | 13.92 |
EV-to-EBITDA | 13.92 |
PEG | 6.89 |
Shares Outstanding M | 587.57 |
Net Margin (%) | 19.31 |
Operating Margin % | 23.15 |
Pre-tax Margin (%) | 23.91 |
Quick Ratio | 3.37 |
Current Ratio | 3.80 |
ROA % (ttm) | 10.57 |
ROE % (ttm) | 13.94 |
ROIC % (ttm) | 18.34 |
Dividend Yield % | 4.09 |
Altman Z-Score | 7.07 |
SZSE:002275 Number of Guru Trades
SZSE:002275 Volume of Guru Trades
Gurus Latest Trades with SZSE:002275
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002275 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guilin Sanjin Pharmaceutical Co Ltd Insider Transactions
No Available Data